Literature DB >> 4037158

Should prisoners be immunized against hepatitis B?

M D Decker, W Schaffrer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037158      PMCID: PMC1646377          DOI: 10.2105/ajph.75.10.1134

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  8 in total

1.  The incidence of hepatitis B in Tennessee prisoners.

Authors:  M D Decker; W K Vaughn; J S Brodie; R H Hutcheson; W Schaffner
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

2.  Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas.

Authors:  J P Koplan; J A Walker; J A Bryan; K R Berquist
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

3.  Incidence of hepatitis B in the penitentiary of New Mexico.

Authors:  H F Hull; L H Lyons; J M Mann; S C Hadler; R Steece; M R Skeels
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

4.  Australia antigen in a closed adult population monitored for serum glutamic oxalacetic transaminase.

Authors:  K A Hok; R Nieman; J O Lackey; V J Cabasso
Journal:  Appl Microbiol       Date:  1970-07

5.  Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff.

Authors:  M Chiaramonte; R Trivello; G Renzulli; L Zampieri; A Fanecco; A Floreani; R Naccarato
Journal:  J Hyg (Lond)       Date:  1982-08

6.  Seroepidemiology of hepatitis B in Tennessee prisoners.

Authors:  M D Decker; W K Vaughn; J S Brodie; R H Hutcheson; W Schaffner
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

7.  Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

Authors:  A G Mulley; M D Silverstein; J L Dienstag
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

8.  Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination.

Authors:  R F Anda; S B Perlman; D J D'Alessio; J P Davis; V N Dodson
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.